AbbVie Inc.
Latest Filing: May 8, 2026 • 25 Total Filings
Total Assets
2026
$136.46B
Total Revenue
2026
$15.00B
Net Income
2026
$695.00M
Operating Cash Flow
2026
$3.83B
Filing Year:
2025
Only 2025 data available
Data Source:
Showing data from all document types
Filters:
AbbVie Inc.
Ticker: ABBV
Legend:
Company
Critical Supplier
Significant Supplier
Standard Supplier
Major Competitor
Emerging Competitor
Competitor